Abstract
Background
In colorectal cancer, tumor budding is highlighted as both a prognostic indicator and a predictor of chemosensitivity. However, tumor budding has a serious drawback because of unattainable preoperative assessment, thereby, making it not applicable to decision-making on treatment strategies. Recently, high expressions of seven genes (i.e., MSLN, SLC4A11, WNT11, SCEL, RUNX2, MGAT3, and FOXC1) were shown to be associated with high-budding colorectal cancers. This study aimed to propose a budding prediction system using selected RNAs extracted from biopsy specimens.
Methods
The RNA expression levels in 86 surgically resected samples and in 104 samples obtained by colonoscopy before surgery were investigated.
Results
The tumor surface expressions of four exclusive genes (i.e., MSLN, SLC4A11, SCEL, and MGAT3) were correlated with the tumor budding grade. Subsequently, the logit P value calculated by multiple logistic regression analysis using the four surface gene expressions was set as the following budding predictive score: Logit (P) = − 0.55 + 0.27*MSLN + 0.16*SLC4A11 + 0.06*MGAT3 + 0.21*SCEL. The effectiveness of the model using colorectal cancer biopsy samples was well corroborated prospectively.
Conclusion
The budding predictive score that we developed using endoscopic biopsy specimens was clarified to have a high potential for preoperative use.
Similar content being viewed by others
References
Lugli A, Kirsch R, Ajioka Y et al (2017) Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Mod Pathol 30:1299–1311
Rogers AC, Winter DC, Heeney A et al (2016) Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer. Br J Cancer 115:831–840
Sy J, Fung CL, Dent OF et al (2010) Tumor budding and survival after potentially curative resection of node-positive colon cancer. Dis Colon Rectum 53:301–307
Shinto E, Jass JR, Tsuda H et al (2006) Differential prognostic significance of morphologic invasive markers in colorectal cancer: tumor budding and cytoplasmic podia. Dis Colon Rectum 49:1422–1430
Ueno H, Murphy J, Jass JR et al (2002) Tumour ‘budding’ as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40:127–132
Ueno H, Ishiguro M, Nakatani E et al (2019) Prospective multicenter study on the prognostic and predictive impact of tumor budding in stage II colon cancer: results from the SACURA trial. J Clin Oncol 37:1886–1894
Yamadera M, Shinto E, Kajiwara Y et al (2019) Differential survival benefits of 5-fluorouracil-based adjuvant chemotherapy for patients with microsatellite-stable Stable III colorectal cancer according to the tumor budding status: a retrospective analysis. Dis Colon Rectum 62:1316–1325
Nagata K, Shinto E, Yamadera M et al (2020) Prognostic and predictive values of tumor budding in stage IV colorectal cancer. BJS Open 4:693–703
Zlobec I, Hädrich M, Dawson H et al (2014) Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients. Br J Cancer 110:1008–1013
Giger OT, Comtesse SC, Lugli A et al (2012) Intra-tumoral budding in preoperative biopsy specimens predicts lymph node and distant metastasis in patients with colorectal cancer. Mod Pathol 25:1048–1053
Lugli A, Vlajnic T, Giger O et al (2011) Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients. Hum Pathol 42:1833–1840
Rogers AC, Gibbons D, Hanly AM et al (2014) Prognostic significance of tumor budding in rectal cancer biopsies before neoadjuvant therapy. Mod Pathol 27:156–162
Shinto E, Yoshida Y, Kajiwara Y et al (2020) Clinical significance of a gene signature generated from tumor budding grade in colon cancer. Ann Surg Oncol 27:4044–4054
Sobin LH, Gospodarowicz MK, Wittekind C (2009) TNM classification of malignant tumors, 7th edn. Wiley-Blackwell, Hoboken
Shiraishi T, Shinto E, Mochizuki S et al (2019) Mesothelin expression has prognostic value in stage II/III colorectal cancer. Virchows Arch 474:297–307
Fukazawa S, Shinto E, Tsuda H et al (2015) Laminin β3 expression as a prognostic factor and a predictive marker of chemoresistance in colorectal cancer. Jpn J Clin Oncol 45:533–540
Youden WJ (1950) Index for rating diagnostic tests. Cancer 3:32–35
Prieve MG, Moon RT (2003) Stromelysin-1 and mesothelin are differentially regulated by Wnt-5a and Wnt-1 in C57 mg mouse mammary epithelial cells. BMC Dev Biol 3:2
Uysal-Onganer P, Kypta RM (2012) Wnt11 in 2011—the regulation and function of a non-canonical Wnt. Acta Physiol (Oxf) 204:52–64
Chou CK, Fan CC, Lin PS et al (2016) Sciellin mediates mesenchymal-to-epithelial transition in colorectal cancer hepatic metastasis. Oncotarget 7:25742–25754
Gaur T, Lengner CJ, Hovhannisyan H et al (2005) Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 280:33132–33140
Shinto E, Tsuda H, Ueno H et al (2005) Prognostic implication of laminin-5 gamma 2 chain expression in the invasive front of colorectal cancers, disclosed by area-specific four-point tissue microarrays. Lab Invest 85:257–266
Kajiwara Y, Ueno H, Hashiguchi Y et al (2011) Expression of l1 cell adhesion molecule and morphologic features at the invasive front of colorectal cancer. Am J Clin Pathol 136:138–144
Kajiwara Y, Ueno H, Hashiguchi Y et al (2011) Heterogeneity of metalloproteinase expression in colorectal cancer—relation of molecular findings to basic morphology. Anticancer Res 31:1567–1575
Shiraishi T, Shinto E, Nearchou IP et al (2020) Prognostic significant of mesothelin expression in colorectal cancer disclosed by area-specific four-point tissue microarrays. Virchows Arch 477:409–420
Shiraishi T, Shinto E, Yamadera M et al (2020) Significance of mesothelin expression in preoperative endoscopic biopsy specimens for colorectal cancer prognosis. Oncotarget 11:3807–3817
Kohler RS, Anugraham M, Lopez MN et al (2016) Epigenetic activation of MGAT3 and corresponding bisecting GlcNAc shortens the survival of cancer patients. Oncotarget 7:51674–51686
De Cristofaro R, De Filippis V (2003) Interaction of the 268–282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII. Biochem J 373:593–601
Ehrlich M (2009) DNA hypomethylation in cancer cells. Epigenomics 1:239–259
Qin L, Li T, Liu Y (2017) High SLC4A11 expression is an independent predictor for poor overall survival in grade 3/4 serous ovarian cancer. PLoS ONE 12:e0187385
Acknowledgements
This work was supported in part by the Japan Society for the Promotion of Science KAKENHI (18K08721). The authors thank Y. Hasumi for the expert technical assistance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Yamadera, M., Shinto, E., Nagata, K. et al. Proposal for a tumor budding predictive score derived from endoscopic biopsy samples in colorectal cancer. Int J Clin Oncol 27, 756–764 (2022). https://doi.org/10.1007/s10147-021-02104-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-021-02104-6